全文获取类型
收费全文 | 5244篇 |
免费 | 527篇 |
国内免费 | 276篇 |
专业分类
电工技术 | 36篇 |
综合类 | 179篇 |
化学工业 | 1554篇 |
金属工艺 | 164篇 |
机械仪表 | 132篇 |
建筑科学 | 648篇 |
矿业工程 | 37篇 |
能源动力 | 17篇 |
轻工业 | 1305篇 |
水利工程 | 56篇 |
石油天然气 | 18篇 |
无线电 | 206篇 |
一般工业技术 | 666篇 |
冶金工业 | 416篇 |
原子能技术 | 81篇 |
自动化技术 | 532篇 |
出版年
2024年 | 9篇 |
2023年 | 176篇 |
2022年 | 212篇 |
2021年 | 928篇 |
2020年 | 299篇 |
2019年 | 271篇 |
2018年 | 178篇 |
2017年 | 211篇 |
2016年 | 204篇 |
2015年 | 225篇 |
2014年 | 352篇 |
2013年 | 318篇 |
2012年 | 271篇 |
2011年 | 302篇 |
2010年 | 287篇 |
2009年 | 277篇 |
2008年 | 260篇 |
2007年 | 253篇 |
2006年 | 181篇 |
2005年 | 146篇 |
2004年 | 133篇 |
2003年 | 111篇 |
2002年 | 104篇 |
2001年 | 48篇 |
2000年 | 56篇 |
1999年 | 26篇 |
1998年 | 38篇 |
1997年 | 26篇 |
1996年 | 18篇 |
1995年 | 21篇 |
1994年 | 19篇 |
1993年 | 15篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 9篇 |
1985年 | 7篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1977年 | 2篇 |
1968年 | 1篇 |
1962年 | 1篇 |
1961年 | 1篇 |
1960年 | 2篇 |
1959年 | 1篇 |
1958年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有6047条查询结果,搜索用时 15 毫秒
31.
海胆酮是一种酮式类胡萝卜素,主要从海胆及藻类等海洋生物中提取。本文研究海胆酮对乙酰胆碱酯酶(acetylcholinesterase,AChE)的抑制作用,应用酶动力学、荧光光谱、圆二色光谱和分子对接技术研究海胆酮对AChE的抑制机理,并用淀粉样β蛋白片段25~35(amyloid beta-peptide 25-35,Aβ25-35)诱导大鼠肾上腺嗜铬细胞瘤细胞(PC12细胞)建立阿尔茨海默症(Alzheimer’s disease,AD)模型,研究海胆酮对AD细胞模型氧化应激损伤的作用。结果表明,海胆酮有很强的AChE抑制活性,其半抑制质量浓度为(16.29±0.97)μg/mL,抑制常数Ki为3.82 μg/mL,表现为竞争性抑制;海胆酮可诱导AChE二级结构改变,更容易与AChE活性中心氨基酸Ser200、His440、Trp84和Tyr121结合,阻碍底物碘代硫代乙酰胆碱(acetylthiocholine iodide,ATCI)与酶结合,从而引起酶活力降低。海胆酮能有效抑制Aβ25-35诱导PC12细胞的AChE活力,降低丙二醛含量,增加超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶活力,减轻Aβ25-35诱导的PC12细胞氧化应激损伤。本研究基于AChE和氧化应激阐明了海胆酮对AD的潜在作用机制,为海胆酮在功能食品、生物医药等领域的应用提供了数据支持和理论根据。 相似文献
32.
33.
34.
P. D. Zalewski J. F. Beltrame A. A. Wawer A. I. Abdo C. Murgia 《Critical reviews in food science and nutrition》2019,59(21):3511-3525
AbstractThe discovery of the roles of nitric oxide (NO) in cardiovascular signaling has led to a revolution in the understanding of cardiovascular disease. A new perspective to this story involving zinc (Zn) is emerging. Zn and its associated Zn transporter proteins are important for the integrity and functions of both the large conduit vessels and the microvascular resistance vessels. The Zn and NO pathways are tightly coordinated. Zn ions are required for the dimerization of endothelial nitric oxide synthase and subsequent generation of NO while generation of NO leads to a rapid mobilization of endothelial Zn stores. Labile Zn may mediate important downstream actions of NO including vascular cytoprotection and vasodilation. Several vascular disease risk factors (including aging, smoking and diabetes) interfere with Zn homeostatic mechanisms and both hypozincaemia and Zn transporter protein abnormalities are linked to atherosclerosis and microvascular disease. Some vegetarian diets and long-term use of certain anti-hypertensives may also impact on Zn status. The available evidence supports the existence of a Zn regulatory pathway in the vascular wall that is coupled to the generation and actions of NO and which is compromised in Zn deficiency with consequent implications for the pathogenesis and therapy of vascular disease. 相似文献
35.
《Planning》2019,(5)
目的探讨彩色多普勒超声测量肾脏叶间动脉阻力指数(resistance index,RI)对Ⅰ型心肾综合征(cardiorenal syndrome,CRS)的诊断价值。方法选取2017年6月1日至2018年3月1日收住民航总医院急诊综合病房并诊断为Ⅰ型CRS的20例患者作为试验组(CRS组),选取同期诊断为单纯急性心力衰竭的患者20例作为对照组,分析两组患者的临床特征、实验室检查及用药情况,并根据受试者工作特征(receiver operating characteristic,ROC)曲线评价肾动脉RI对Ⅰ型CRS的诊断价值。结果两组患者年龄、左心室射血分数、心功能分级、心率及脉压差差异无统计学意义(P均>0. 05),CRS组患者的氨基末端脑钠尿肽、肌酐水平、呋塞米剂量以及肾动脉RI均高于对照组,而肾小球滤过率低于对照组,差异具有统计学意义(P均<0. 05)。ROC曲线下面积为0. 78,取最佳截点值0. 70时预测Ⅰ型CRS的敏感度为80%,特异度为80%。结论作为一种新的手段,肾动脉RI可与传统方法相互补充,对诊断Ⅰ型心肾综合征患者具有潜在应用价值。 相似文献
36.
Histone deacetylase inhibitors (HDACIs) are responsible for controlling gene expression by modulating the acetylation status of histone proteins. Furthermore, they modulate the activity of cytoplasmic non-histone proteins. Due to the involvement of HDACs in neurodevelopment, memory formation, and cognitive processes, HDACIs have been suggested as innovative agents for the treatment of neurodegenerative disorders such as Alzheimer's disease (AD). Given their mechanisms of action and the complex nature of AD, HDACIs have been proposed for the design of novel multitarget ligands (MTLs). To this aim, the fragment responsible for HDAC inhibition has been coupled with other structures that are able to provide additional biological actions, such as antioxidant activity or the inhibition of phosphodiesterase 5, transglutaminase 2, and glycogen synthase kinase 3β. Herein we discuss recent efforts to design HDACI-based MTLs as potential disease-modifying entities. 相似文献
37.
38.
39.
Ionomics is a novel multidisciplinary field that uses advanced techniques to investigate the composition and distribution of all minerals and trace elements in a living organism and their variations under diverse physiological and pathological conditions. It involves both high-throughput elemental profiling technologies and bioinformatic methods, providing opportunities to study the molecular mechanism underlying the metabolism, homeostasis, and cross-talk of these elements. While much effort has been made in exploring the ionomic traits relating to plant physiology and nutrition, the use of ionomics in the research of serious diseases is still in progress. In recent years, a number of ionomic studies have been carried out for a variety of complex diseases, which offer theoretical and practical insights into the etiology, early diagnosis, prognosis, and therapy of them. This review aims to give an overview of recent applications of ionomics in the study of complex diseases and discuss the latest advances and future trends in this area. Overall, disease ionomics may provide substantial information for systematic understanding of the properties of the elements and the dynamic network of elements involved in the onset and development of diseases. 相似文献
40.
The mammalian cell cycle is important in controlling normal cell proliferation and the development of various diseases. Cell cycle checkpoints are well regulated by both activators and inhibitors to avoid cell growth disorder and cancerogenesis. Cyclin dependent kinase 20 (CDK20) and p21Cip1/Waf1 are widely recognized as key regulators of cell cycle checkpoints controlling cell proliferation/growth and involving in developing multiple cancers. Emerging evidence demonstrates that these two cell cycle regulators also play an essential role in promoting cell survival independent of the cell cycle, particularly in those cells with a limited capability of proliferation, such as cardiomyocytes. These findings bring new insights into understanding cytoprotection in these tissues. Here, we summarize the new progress of the studies on these two molecules in regulating cell cycle/growth, and their new roles in cell survival by inhibiting various cell death mechanisms. We also outline their potential implications in cancerogenesis and protection in heart diseases. This information renews the knowledge in molecular natures and cellular functions of these regulators, leading to a better understanding of the pathogenesis of the associated diseases and the discovery of new therapeutic strategies. 相似文献